Cerebellar volume as imaging outcome in progressive multiple sclerosis

Area of Science:

• Neuroimaging
• Neurology
• Clinical Trials

Background:

• Primary-progressive multiple sclerosis (PPMS) is a debilitating neurological condition.
• Identifying sensitive outcome measures for clinical trials is crucial for developing effective treatments.

Purpose of the Study:

• To evaluate cerebellar volume changes as a potential sensitive outcome measure in primary-progressive MS.
• To assess the utility of cerebellar metrics in monitoring treatment effects in clinical trials.

Main Methods:

• Longitudinal assessment of cerebellar volumes using Freesurfer in PPMS patients and controls.
• Correlation of volume changes with clinical disability worsening (EDSS, walk tests).
• Validation in an independent cohort.

Main Results:

• Significant reductions in cerebellar volume and cerebellar cortex volume observed in clinically progressed patients.
• High diagnostic accuracy (AUC 0.91-0.96) for cerebellar metrics differentiating progressors from non-progressors.
• Consistent findings across exploration and validation cohorts.

Conclusions:

• Cerebellar volume and cerebellar cortex volume are proposed as potential short-term imaging biomarkers.
• These metrics could enhance the monitoring of treatment efficacy in PPMS clinical trials.